Abstract Submission Guideline
(Poster Presentation)
IBRO – APRC Associate School of Neuroscience 2013
17th Thai Neuroscience Society International Conference
July 29 – August 3, 2013
1. The abstract must be written in English, typed in ‘Times New Roman’ font, 12 points, and must not exceed 300 words (excluding Title, Author(s), Institution(s), and Keywords). The margin of A4 size is one inch or 2.5 cm on each side. Please fill them in the attached form.
2. In the abstract, the topic must be BOLD, no indent is needed, and start a new paragraph when the topic changes.
2.1 Title: Always use capital letter with the first alphabet, except prepositions and scientific terms of species. Must not be beyond 2 lines.
2.2 Author(s): Identify full name and last name of authors without qualification and position. Underline the name of the presenting author.
2.3 Institution(s): Type in italic. If the authors are from different affiliations, please use number 1, 2, 3 … for superscript and alternate with colon (,). Please begin with Department, Faculty and Institution. For external sectors, please start with Division.
2.4 Background: a brief introductory statement of the research
2.5 Objective(s)
2.6 Material(s) and Method(s)
2.7 Results
2.8 Conclusion
2.9 Acknowledgement (source of funding)
2.10 Keywords: 3-5 words (not present in the title)
3. Language in the abstract must be appropriate and grammatically accurate. For scientific names, please underline the word, so that the publisher will turn them into italic.
4. Standard abbreviations should be used throughout. Any special or unusual abbreviations should be spelled out in full at first mention, followed by the abbreviation in parentheses. It is recommended that you use a minimum number of abbreviations in your abstract.
5. Press 1 space bar between words, press 2 space bars between sentences. Punctuation mark must be close the previous word, then, press 1 space bar. Do not try to start a new paragraph.
6. The committee will not accept the abstract without results.
7. Check carefully for any misspellings and/or typographical errors.
8. Deadline for submission is June 30, 2013.
9. Please save the abstract file in .doc or .docx (NOT .pdf) and submit the abstract via e-mail to .
10. The abstract must not be published in any publication.
11. The abstract must not be in any proceeding.
Remark: No fee charged for abstract submission. If the abstract preparation is not consistent with the guideline above or submitted after the deadline, the committee may not be able to publish your work in the abstract book. The abstract that is selected by the committee will be published in the abstract book.
IBRO – APRC Associate School of Neuroscience 2013
17th Thai Neuroscience Society International Conference
Title:Author(s):
Institution(s):
Background:
Objective(s):
Material(s) and Method(s):
Results:
Conclusion:
Acknowledgement:
Keyword(s):
Time-Course Study Of Soluble E-Selectin In Cardiac Surgical Patients Undergoing Cardiopulmonary Bypass Technique
Watchara Kaewmahanin1*, Luecha Boontaveekul1, Wattana B Watanapa1, Punnarerk Thongchareon2
1Department of Physiology and 2Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
E-mail: (Dr. Luecha Boontaveekul)
Background: The myocardial infarction after ischemia-reperfusion injury (I/R) is a major adverse effect of postoperative cardiac surgery with a cardiopulmonary bypass (CPB) technique. This complication must be detected immediately in order to prevent mortality and morbidity. Standard cardiac markers have limitations and cannot serve as indices for early detecting the myocardial infarction after cardiac surgery. We hypothesize that soluble E-selectin (sE-selectin) may be an early predictive marker for myocardial infarction after cardiac surgery with CPB. However, previous evidence showed no consensus on the time course of increased sE-selectin level.
Objective: To identify the time-course of sE-selectin rising in cardiac surgical patients undergoing CPB technique.
Methods: Twelve patients (age 20 – 60 years) who underwent the first-time elective mitral valve surgery or ventricular septal defect (VSD) closure were recruited. Serial blood samples were collected from right atrial catheter at the preoperative time (baseline), the time that the aorta was clamped (t = 0) and the 1, 3, 6, 9, 12, 24, 36 and 48 hours after operation. The initial time point of myocardial ischemia (t = 0) could be clearly identified since it did not present before aortic cross clamping. The sE-selectin levels were measured with an ELISA technique. Creatinine kinase isoenzyme MB (CK-MB) and troponin T (Tn-T) levels were analyzed by Siriraj central lab facility.
Results: The median of sE-selectin level at the baseline was 33.88 ng/ml and the 25th to 75th percentile range of the same time was 25.60 to 41.71 ng/ml. It increased rapidly in 3 hours and reached the maximum in 6 hours (median: 69.64 ng/ml, 25th - 75th percentile range: 51.71 - 95.08 ng/ml) and decreased to baseline in 48 hours after surgery, (median: 42.04 ng/ml, 25th - 75th percentile range: 34.75 - 62.52 ng/ml). The sE-selectin levels at the baseline, 24 and 48 hours after operation also correlated with CK-MB (r=0.452, p=0.009) and Tn-T (r=0.481, p=0.005).
Conclusion: This study indicates that the sE-selectin levels increase rapidly to the maximum within 6 hours after operation with CPB technique and correlate with gold standard markers (CK-MB, Tn-T). However, whether sE-selectin can be used as a marker of myocardial injury needs further studies.
Supported by The Siriraj Research Development Fund, Faculty of Medicine Siriraj Hospital and The Thesis Scholarship, Faculty of Graduate Studies, Mahidol University (2005).
Keywords: ischemia-reperfusion injury, cardiac marker, cardiac surgery, cardiopulmonary bypass technique, soluble E-selectin,
Guideline for Poster Preparation
IBRO – APRC Associate School of Neuroscience 2013
17th Thai Neuroscience Society International Conference
July 29 – August 3, 2013
· The posters should be readable from at least 5 feet away.
· The figures and tables should be clear and the contents of the posters should be understandable by reading.
· Do not overload the posters as more material may mean less communication.
· The dimension for each poster (w x h) is vertical; 62 cm x 95 cm.
· The thickness of posters should not be beyond 0.5 cm
· Posters accepted will be assigned a number. Please consult the Symposium program for the time for poster set up and teardown.
· Authors presenting posters are requested to be available for answering the questions during the poster display. Please consult the Symposium program for the time for poster display
Guideline for Proceedings Preparation
IBRO – APRC Associate School of Neuroscience 2013
17th Thai Neuroscience Society International Conference
July 29 – August 3, 2013
1. Proceedings must be typewritten in English (US) with double-spacing throughout and with all margins at least 2 cm. Times New Roman (size 12) alphabets are recommended.
2. Please be reminded that research works to be submitted for PROCEEDINGS do not need to be completed but should have certain progress, and need to be NEUROSCIENCE or NEUROLOGY-related.
3. Proceedings should be concisely written in a readily understandable style. Technical jargon, laboratory slang or words not defined in dictionaries should not be used. Abbreviations should be avoided. They must not be used as a short form for experimental procedures or for contents. Redundant words, phrases, and sentences should not be used. For example, the captions to Tables and Figures, with or without paraphrasing, should not be repeated in the text.
4. Each proceeding should be prepared in the following order.
(a) Title page: The title page should have the title, full names and degrees of each author, each author’s affiliation, and the name and address of the corresponding author. The title length should not exceed 25 words.
(b) Abstract: Each proceeding should contain structured abstract of no more than 300 words and should include background, methods, results, conclusions. Five suitable keywords must be given at the end of the abstract.
(c) Content: Each proceeding should be prepared in the following order. Introduction, Materials and Methods, Results, Discussion, Acknowledgements, Conflict of interest, References, Figure Legends, Tables, and Figures.
Introduction: An introductory statement should first "set the scene" for a non-specialist and then continue with the specific reasons for undertaking the investigation. The main objective of the study must be clearly indicated. Exhaustive reviews of the literature should be avoided and no attempt should be made to indicate the results obtained.
Materials and Methods: In this section, experimental procedures used should be given in sufficient details to permit the repetition of the work by others. However, published procedures should only be briefly summarized and only described in details if they have been substantially modified. Special chemicals, drugs, etc. with their sources of supply should also be described.
Results: The findings should be concisely and sequentially described without discussion of their significance. All Tables and Figures of the result must be cited in the text. Sub-sections should be used in order to clarify the expression of the results.
Discussion: The authors' interpretations of their findings should be accompanied by an assessment of their significance in relation to previous works and possible mechanisms should be proposed. Repetition of material given under "Results" should be avoided. Sub-sections should be used wherever possible. Stating the main finding in the first paragraph and the conclusion at the end is recommended.
Acknowledgements: All sources of funding supports and contributions from co-workers should be stated here.
Conflict of interest: Each author’s conflict of interest is to be declared. If there is no conflict of interest, “None to declare” should be stated.
References: The Vancouver system should be used. In the text, references should be cited numerically in the order as they appear, each identified by an arabic number as superscripts. The number(s) must be put after a punctuation. For example, "Osteoporosis is an asymptomatic bone disease.1" In the reference list, the references must be numbered and listed in the order of appearance in the text. In each cited reference, if there are more than six authors, only the name of the first three authors are given followed by the words "et al." If there are six authors or fewer, list all author names. The name of each cited journal should be abbreviated using Index Medicus style.
Journal article
Watanapa WB, Theerathananon W, Akarasereenont P, Techatraisak K. Effects of preeclamptic plasma on potassium currents of human umbilical vein endothelial cells. Reprod Sci. 2012; 19(4): 391-9.
Book chapter
Srisuma S, Wagner EM. Chemokine regulation of angiogenesis. In: Lazaar A, editor. Bronchial vascular remodeling in asthma and COPD, Lung biology in health and disease series. New York: Marcel Dekker; 2006. p. 95-114.
Book
Boron WF, Boulpaep EL, editors. Medical physiology. 2nd ed. Philadelphia: Saunders; 2009.
Unpublished experiments, papers in preparation, etc. may be mentioned only in the text; they must not be included in the list of References.
A paper which has been accepted for publication but which has not appeared may be cited in the References with the abbreviated name of the journal followed by the words "In press". The date of acceptance of each such paper should be indicated.
Personal communications may be used only when written authorization from the communicator is submitted with the original manuscript; they may be mentioned only in the text.
Figure Legends: This should be on a separate page and describe brief details of each figure.
Tables: Each table should be on a separate page. In general, Tables and Figures should be constructed so that they, together with their captions and legends, are intelligible with minimal reference to the text.
Figures: Each figure should be on a separate page. Care should be taken to present data in a precise manner. For example, histograms should not be used when the data can equally well be given in a table. High-resolution black and white figures are preferable. Files of all illustrations should be submitted in a form suitable for direct reproduction. Color figures can also be submitted.
5. Pages should be numbered in succession, the title page being page 1.
6. Drug names should be the official or approved names; trade names or common names may be given in brackets where the drug is first mentioned. The manufacturer's name must be given. The doses of the drugs should be given as unit weight per unit body weight, e.g. mmol/kg or mg/kg, concentrations should be given in terms of molarity, e.g. mM or mM or as unit weight/unit volume solution, stating whether the weight refers to the salt or the active component of the drug. The molecular weight, inclusive of water of crystallization, should be stated if doses are given as unit weight.
7. Deadline for submission is June 30, 2013.
8. Please save the proceeding file in .doc or .docx (NOT .pdf) and submit the abstract via e-mail to .
9. The proceeding must not be published in any publication.
Ethical Consideration
· Research involving animals must adhere to NIH Guiding Principles in the Care and Use of Animals. All investigations involving humans or animals reported in its publications be conducted in conformity with these principles, and that a statement of protocol approval form an IRB or IACUC or equivalent is included in the methods section of the paper. Manuscripts reporting the results of experiments on human subjects, including healthy volunteers, must include a statement that informed consent was obtained.
Abbreviations
1. Symbols for physical units should be restricted to the SI units (Le Système International d'Unités or the International System of Units). Examples of commonly used symbols can be found in Biochem J 145: 1-20, 1975 and more detailed description, in Quantities, Units and Symbols (1971), The Royal Society, London.
2. The excessive use of abbreviation in the text is strongly discouraged. In particular, awkward and unfamiliar abbreviations and those intended to express concepts or experimental techniques will not be permitted. In order to aid communication between scientists of different disciplines, authors should only use abbreviations sparingly and should always define the abbreviation when first used by placing it in parenthesis after the full term, e.g. acetylcholinesterase (AChE).
Remark:
· No fee charged for submission and publication of proceeding.
· If the proceeding preparation is not consistent with the guideline above or submitted after the deadline, the committee may not be able to publish your work in the proceeding book. The proceeding that is selected by the committee will be published in the proceeding book.
· The thesis presented and published as the Proceedings for IBRO – APRC Associate School of Neuroscience 2013 & 17th Thai Neuroscience Society International Conference can be qualified for Graduation in a Master’s Degree Program (depending upon the degree’s regulation).